Most patients also believed that once-weekly dosing was more convenient than once-daily dosing ( 89.0 % vs 7.7 % ; P < 0.001 ) and would allow them to achieve better long-term compliance ( 87.5 % vs 8.5 % ; P < 0.001 ) .
